14 research outputs found
Value of Epidermal Growth Factor Receptor, HER2, p53, and Steroid Receptors in Predicting the Efficacy of Tamoxifen in High-Risk Postmenopausal Breast Cancer Patients
No full textEP-1360: Comparing patient and physician-reported GI effects in locally advanced prostate cancer radiotherapy
No full textPO-0732: Temporal patterns of patient-reported symptom groups after prostate cancer radiotherapy
No full textSP-0171: Pediatric Normal Tissue Effects in the Clinic (PENTEC): An international collaboration
Get PDFSP-0171: Pediatric Normal Tissue Effects in the Clinic (PENTEC): An international collaboration
No full text
Understanding High-Dose, Ultra-High Dose Rate, and Spatially Fractionated Radiation Therapy.
Get PDFThe National Cancer Institute's Radiation Research Program, in collaboration with the Radiosurgery Society, hosted a workshop called Understanding High-Dose, Ultra-High Dose Rate and Spatially Fractionated Radiotherapy on August 20 and 21, 2018 to bring together experts in experimental and clinical experience in these and related fields. Critically, the overall aims were to understand the biological underpinning of these emerging techniques and the technical/physical parameters that must be further defined to drive clinical practice through innovative biologically based clinical trials
